- Report
- April 2025
- 182 Pages
Global
From €2220EUR$2,500USD£1,925GBP
- Report
- March 2025
- 210 Pages
Global
From €2220EUR$2,500USD£1,925GBP
- Report
- March 2025
- 205 Pages
Global
From €2220EUR$2,500USD£1,925GBP
- Report
- March 2025
- 255 Pages
Global
From €2220EUR$2,500USD£1,925GBP
- Report
- March 2025
- 228 Pages
Global
From €2220EUR$2,500USD£1,925GBP
- Report
- March 2025
- 226 Pages
Global
From €2220EUR$2,500USD£1,925GBP
- Report
- March 2025
- 222 Pages
Global
From €2220EUR$2,500USD£1,925GBP
- Report
- March 2025
- 217 Pages
Global
From €2220EUR$2,500USD£1,925GBP
- Report
- March 2025
- 194 Pages
Global
From €2220EUR$2,500USD£1,925GBP
- Report
- February 2025
- 247 Pages
Global
From €2220EUR$2,500USD£1,925GBP
- Report
- February 2025
- 252 Pages
Global
From €2220EUR$2,500USD£1,925GBP
- Report
- February 2025
- 231 Pages
Global
From €2220EUR$2,500USD£1,925GBP
- Report
- February 2025
- 233 Pages
Global
From €2220EUR$2,500USD£1,925GBP
- Report
- February 2025
- 215 Pages
Global
From €2220EUR$2,500USD£1,925GBP
- Report
- February 2025
- 221 Pages
Global
From €2220EUR$2,500USD£1,925GBP
- Report
- February 2025
- 214 Pages
Global
From €2220EUR$2,500USD£1,925GBP
- Report
- January 2025
- 193 Pages
Global
From €2220EUR$2,500USD£1,925GBP
- Report
- January 2025
- 189 Pages
Global
From €2220EUR$2,500USD£1,925GBP
- Report
- January 2025
- 199 Pages
Global
From €2220EUR$2,500USD£1,925GBP
- Report
- January 2025
- 192 Pages
Global
From €2220EUR$2,500USD£1,925GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more